Laura Pandolfi
- Acid sphingomyelinase mediates IL-6 release in experimental LPS-induced lung injuryBy Rachele Pandolfi, Bianca Barreira, Andrea Martinez-Ramas, Enrique Moreno, Victor Lara-Acedo, Daniel Morales-Cano, Virginia Chamorro, Angel Cogolludo, Francisco Pérez-Vizcaíno F and Laura MorenoRachele Pandolfi1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainBianca Barreira1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainAndrea Martinez-Ramas1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainEnrique Moreno1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainVictor Lara-Acedo1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainDaniel Morales-Cano1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainVirginia Chamorro1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainAngel Cogolludo1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainFrancisco Pérez-Vizcaíno F1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainLaura Moreno1Pharmacology, School of Medicine, Universidad Complutense de Madrid and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cellsBy Daniel Morales-Cano, Bianca Barreira, Virginia Chamorro, Rachele Pandolfi, Beatriz De Olaiz Navarro, Andrés Esteban, Julio Cortijo, Ángel Cogolludo, Laura Moreno and Francisco Pérez-VizcaínoDaniel Morales-Cano1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainBianca Barreira1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainVirginia Chamorro1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainRachele Pandolfi1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainBeatriz De Olaiz Navarro2Department of Thoracic Surgery and Critical Care, Hospital Universitario de Getafe, Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainAndrés Esteban2Department of Thoracic Surgery and Critical Care, Hospital Universitario de Getafe, Ciber Enfermedades Respiratorias (CIBERES), Madrid, SpainJulio Cortijo3Pharmacology, Universidad de Valencia, Ciber de Enfermedades Respiratorias (CIBERES), Valencia, SpainÁngel Cogolludo1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainLaura Moreno1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia SpainFrancisco Pérez-Vizcaíno1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber Enfermedades Respiratorias (CIBERES), Madrid, Andalucia Spain
- Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalationBy Emanuela Cova, Gabriele Ceccarelli, Laura Pandolfi, Manuela Agozzino, Raffaele Allevi, Laura Benedetti, Miriam Colombo, Simona Inghilleri, Sara Magni, Tiberio Oggionni, Davide Prosperi, Maria Gabriella Cusella and Federica MeloniEmanuela Cova1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyGabriele Ceccarelli2Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, ItalyLaura Pandolfi3Department of Biothecnology and Biosciences, University of Milano-Bicocca, Milano, ItalyManuela Agozzino5Center for Inherited Cardiovascular Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyRaffaele Allevi4Department of Clinical Sciences "L. Sacco", University of Milan, Milano, ItalyLaura Benedetti2Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, ItalyMiriam Colombo3Department of Biothecnology and Biosciences, University of Milano-Bicocca, Milano, ItalySimona Inghilleri1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalySara Magni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyTiberio Oggionni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyDavide Prosperi3Department of Biothecnology and Biosciences, University of Milano-Bicocca, Milano, ItalyMaria Gabriella Cusella2Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, ItalyFederica Meloni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, Italy
- Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro studyBy Giulia Stella, Emanuela Cova, Simona Inghilleri, Davide Piloni, Miriam Colombo, Simona Mrakic-Sposta, Laura Pandolfi, Angelo Corsico, Ymera Pignochino, Davide Prosperi, Patrizia Morbini and Federica MeloniGiulia Stella1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyEmanuela Cova1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalySimona Inghilleri1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyDavide Piloni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyMiriam Colombo2Biotechnology and Bioscience Department, Milano-Bicocca University, Milano, ItalySimona Mrakic-Sposta3Istitute of Physiology and Molecular Bioimaging, IBFM – CNR, Milano, ItalyLaura Pandolfi2Biotechnology and Bioscience Department, Milano-Bicocca University, Milano, ItalyAngelo Corsico1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyYmera Pignochino4Oncology Division, IRCCS Candiolo, Torino, ItalyDavide Prosperi2Biotechnology and Bioscience Department, Milano-Bicocca University, Milano, ItalyPatrizia Morbini5Department of Pathology, IRCCS Policlinico San Matteo, Pavia, ItalyFederica Meloni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, Italy
- Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severityBy Michele Zorzetto, Laura Pandolfi, Simona Inghilleri, Laura Dovizia, Monica Morosini, Angelo Corsico, Davide Piloni, Giulia Stella, Federica Meloni and Emanuela CovaMichele Zorzetto1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyLaura Pandolfi2Department of Biothecnology and Biosciences, University of Milano-Bicocca, Milano, ItalySimona Inghilleri1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyLaura Dovizia1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyMonica Morosini1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyAngelo Corsico1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyDavide Piloni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyGiulia Stella1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyFederica Meloni1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, ItalyEmanuela Cova1Department of Respiratory Diseases, IRCCS Policlinico San Matteo, Pavia, Italy
- Monosodium urate crystals stimulate IL-6 production via TAK1 and induce pulmonary vascular dysfunctionBy Laura Moreno, Andrea Martínez-Ramas, Bianca Barreira, Rachele Pandolfi, Beatriz De Olaiz Navarro, Daniel Morales-Cano, Raquel Herrero, Jóse Ángel Lorente, Ángel Cogolludo and Francisco Pérez-VizcaínoLaura Moreno1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainAndrea Martínez-Ramas1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainBianca Barreira1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainRachele Pandolfi1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainBeatriz De Olaiz Navarro2Department of Thoracic Surgery and Department of Critical Care, Hospital Universitario de Getafe and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainDaniel Morales-Cano1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainRaquel Herrero2Department of Thoracic Surgery and Department of Critical Care, Hospital Universitario de Getafe and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainJóse Ángel Lorente2Department of Thoracic Surgery and Department of Critical Care, Hospital Universitario de Getafe and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainÁngel Cogolludo1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, SpainFrancisco Pérez-Vizcaíno1Department of Pharmacology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) and Ciber de Enfermedades Respiratorias (CIBERES), Madrid, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.